Trace analysis of therapeutic inertia and subsequent hemoglobin A1c outcomes in a 2-year cohort study
Journal
European Review for Medical and Pharmacological Sciences
Journal Volume
25
Journal Issue
9
Pages
3499
Date Issued
2021
Author(s)
Abstract
Our understanding of therapeutic inertia in diabetes care is incomplete in terms of an assessment across a nationwide population. The key objectives of this investigation were to measure therapeutic inertia and link this phenomenon to the important surrogate outcome of hemoglobin A1c (HbA1c) control in a nationwide cohort.
Subjects
Therapeutic inertia; Intensified therapy; HbA1c; Diabetes mellitus; CLINICAL INERTIA; DIABETES-MELLITUS; PREVALENCE; PEOPLE
SDGs
Other Subjects
acarbose; buformin; chlorpropamide; glibenclamide; gliclazide; glimepiride; gliquidone; hemoglobin A1c; insulin; metformin; nateglinide; pioglitazone; repaglinide; rosiglitazone; sulfonamide; sulfonylurea derivative; tolazamide; antidiabetic agent; glycos
Publisher
VERDUCI PUBLISHER
Type
journal article